There are 27 papers on THRB in aging research: 1 trial and 2 observational studies in people, 8 in animals, 1 in cells, 13 reviews.
5 new papers in 30 daysSee all 27 papers on THRB
At a glance
The findings reach mice, none yet in people. 3 independent labs in 2 countries; 25 trials, 9 with no results posted.
None of its findings points the other way.
Cells and mice: a single group. Worms or flies and humans: nothing yet.
- 3 independent labs in 2 countries
- 25 trials, 9 with no results posted
- Funders: National Institutes of Health and 7 more
- 17 of 25 trials sponsored by developers of drugs aimed at it
- Human trial1
- Humans2
- Animals8
- Cells1
- In silico2
Interventions
2Thyroxine
upin mice1
1 study
Thyroxine
upin mice1
Thyroxine increases THRB in mice.
Animals
Fasting
downin M. angustirostris1
1 study
Fasting
downin M. angustirostris1
Fasting decreases THRB in M. angustirostris (30-fold).
Animalsmuscle8 weeksmales
Effects
1Latest
14 papers in 12 monthsAHA Scientific Sessions 2026 Abstract
Cardiometabolic Outcomes of Resmetirom Modeled Projection of Atherosclerotic Cardiovascular Disease Risk Reduction: Systematic Review and Meta-Analysis
Meta-analysis of randomized trialsResmetirom
Current Opinion in Nephrology and Hypertension
Integrating the liver into the cardiovascular-kidney-metabolic syndrome: pathophysiology and therapeutic implications
Expert Opinion on Pharmacotherapy
Emerging pharmacotherapies for androgenetic alopecia
ReviewAndrogenetic alopecia
Cureus
THR-β Agonists vs Incretin Therapies for Noncirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Biopsy-Anchored Systematic Review With Grading of Recommendations Assessment, Development and Evaluation (GRADE) Certainty
Systematic review of randomized trialsGLP-1 receptor agonists
Cost Effectiveness and Resource Allocation
Semaglutide versus resmetirom for noncirrhotic MASH with moderate to advanced fibrosis: a cost-effectiveness analysis
Computational studyResmetirom